Baluch Khoso
- SEC CIK
- 0001686223
In the past year, 1 open-market purchase filing worth $5.76K and no sales.
Current role at each company
- PCSA Processa Pharmaceuticals, Inc.Directoras of Jul 28, 2026
- LGVN Longeveron Inc.Directoras of Aug 13, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $5.76K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$5.76K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Baluch Khoso as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PCSA Processa Pharmaceuticals, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 (view filing) | Mar 31 | 1 day | Baluch KhosoDirector | PPurchase | +2.27K | $2.54 | +$5.76K | +4,051.8%2.33K after |
LGVN Longeveron Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2025 (view filing) | Aug 11 | 2 days | Baluch KhosoDirector | PPurchaseClass A Common Stock | +11.8K | – | – | +28.9%52.5K after | |
| Aug 13, 2025 (view filing) | Aug 11 | 2 days | Baluch KhosoDirector | PPurchaseClass A Common Stock | +29.4K | – | – | –29.4K after | Derivative |
| Dec 4, 2024 (view filing) | Dec 2 | 2 days | Baluch KhosoDirector | SSaleClass A Common Stock | −1.25K | $2.07 | −$2.59K | −5.0%23.8K after | |
| Jan 2, 2024 (view filing) | Dec 28-29, 2023 | 5 days | Baluch KhosoDirector | PPurchase | +10.0K | $1.42 | +$14.2K | +200.0%15.0K after | 2 lots |